oasis 1 oral semaglutide 50 mg nejm 2023 obesity trial Higher-dose oral semaglutide may be beneficial option for type 2 diabetes, obesity 🥼🧪Slide Deck: Efficacy and safety

2.8% for 16 months, and 1.4% for 18 months

4.1 Phytochemical In T2DM, high glucose and fatty acids impair endothelial NO synthase phosphorylation, leading to decreased NO levels and increased ET-1 synthesis

Its also wise to be cautious when using it with potent immunosuppressants due to its immunomodulatory effects

Receiving this form of injection provides a direct and efficient way to boost B12 levels in the body, bypassing potential absorption issues in the digestive system

Neither lane is better than the other

With this holistic approach, patients report not only significant weight loss but also improved energy, mood, and overall health